PMR Press Release

2018-2023 Global Subcutaneous Immunoglobulins Consumption Market Report No ratings yet.

Subcutaneous Immunoglobulins Consumption Market Synopsis:

In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global Subcutaneous Immunoglobulins market for 20182023.

Subcutaneous Immunoglobulin SCIg infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump spring loaded or battery powered or by rapid push a manual method that does not require a pump.
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.
Market competition is intense. In United States, only Shire Baxalta, Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with highend customers; have been formed in the monopoly position in the industry.
Over the next five years, LPILP Information projects that Subcutaneous Immunoglobulins will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunoglobulins market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
10% Purity
20% Purity
Segmentation by application:
Primary Immunodeficiency
Secondary Immunodeficiency
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Shire Baxalta
Grifols
CSL


In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Subcutaneous Immunoglobulins consumption value & volume by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Subcutaneous Immunoglobulins market by identifying its various subsegments.
Focuses on the key global Subcutaneous Immunoglobulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Subcutaneous Immunoglobulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
To project the consumption of Subcutaneous Immunoglobulins submarkets, with respect to key regions along with their respective key countries.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please rate this

Leave a Reply

Close Menu